Who owns Calliditas Therap Adr Rep 2 Ord sponsored adr?

Tip: Access positions for across all investors

Analyze quarterly positions in Calliditas Therap Adr Rep 2 Ord with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Calliditas Therap Adr Rep 2 Ord stock

Who bought or sold Calliditas Therap Adr Rep 2 Ord sponsored adr this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
BVF 750k $19M 0% Dec 2023
 View chart
Deutsche Bank Aktiengesellschaft 51k $1.3M -44% Dec 2023
 View chart
Ironwood Investment Management 25k $655k -5% Dec 2023
 View chart
Susquehanna International 22k $404k 100% Sep 2023
 View chart
Citadel Advisors 20k $514k 51% Dec 2023
 View chart
Morgan Stanley 2.3k $43k -12% Sep 2023
 View chart
Wells Fargo & Company 1.5k $39k 100% Dec 2023
 View chart
Advisor Group Holdings 1.2k $30k 0% Dec 2023
 View chart
UBS Group 952.00 $25k 2222% Dec 2023
 View chart
Planning Capital Management Corp 877.00 $23k 100% Dec 2023
 View chart
Jpmorgan Chase & Co 607.00 $16k 232% Dec 2023
 View chart
Simplex Trading 324.00 $8.0k -40% Dec 2023
 View chart
Bank of America Corporation 313.00 $8.1k -59% Dec 2023
 View chart
Rhumbline Advisers 164.00 $4.2k 10% Dec 2023
 View chart
Colonial Asset Management 105.00 $1.9k 0% Sep 2023
 View chart
Cutler 100.00 $2.0k 100% Dec 2023
 View chart
Qube Research & Technologies 72.00 $1.3k 100% Sep 2023
 View chart
Missouri Trust & Investment 35.00 $901.001500 0% Dec 2023
 View chart
Nalls Sherbakoff Group 35.00 $639.999500 0% Sep 2023
 View chart

Who sold out of Calliditas Therap Adr Rep 2 Ord?

Fund or Company Name Date Sold Shares Held Valued At
Sphera Funds Management Sep 2023 12k $217k
Optiver Holding B.V. Jun 2023 5.0k $79k